Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you stop taking Mounjaro, most people regain a significant portion of the weight they lost, often within months. This is not a personal failure. Tirzepatide works by mimicking gut hormones that suppress appetite and slow gastric emptying; once those signals are withdrawn, hunger returns and the body's weight-regulating mechanisms revert to their previous set point. Clinical evidence from the SURMOUNT programme, as assessed by NICE in their appraisal of tirzepatide (TA1026), makes clear that the medicine's effects are not permanent once treatment ends. These are prescription-only medicines; any decision about continuing, pausing or stopping should be made with the prescriber who oversees your care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is: for most people, yes. Tirzepatide is effective while you take it because it actively changes the hormonal environment that governs how hungry you feel and how quickly your stomach empties. Stop the injections, and those effects stop with them. The underlying biology that made weight loss difficult in the first place does not disappear.
Evidence from within the SURMOUNT clinical programme supports this. Participants who lost significant weight during treatment and then discontinued saw meaningful regain in the months that followed, a pattern also observed across other GLP-1 and dual-agonist trials. The NHS tirzepatide medicines page reflects this understanding: Mounjaro is described as a long-term weight management medicine, not a short course.
The degree of regain varies between individuals. People who have made durable changes to their eating patterns and activity levels during treatment tend to regain less. But for most, stopping entirely without those foundations in place means weight drifts back, often to near the original starting point within a year or two, and you can read about what happens when you stop using Mounjaro to understand why that pattern is so consistent. That is not a reflection on effort or willpower; it is how this class of medicine works.
If you are thinking about what stopping means for you specifically, a prescriber can help you weigh up timing, the state of your progress, and what support is available. You can read more about stopping Mounjaro and weight loss outcomes in detail.
The physiological changes after your final dose happen in sequence rather than all at once. Tirzepatide's half-life means it stays active for roughly five days after injection, so the transition is not instant. Over the first one to two weeks, as the medicine clears your system, appetite typically begins to increase. Portion sizes that felt comfortable during treatment may start feeling insufficient. Cravings, particularly for calorie-dense foods, often return.
Gastric emptying speeds back up to its normal rate, which means meals feel less filling and satiety signals to the brain diminish. Concurrently, some of the metabolic improvements gained during treatment, such as improvements in blood glucose regulation, may begin to reverse, depending on how much weight was lost and how long treatment continued.
None of this is an emergency. Stopping Mounjaro does not cause withdrawal in the clinical sense. Most people feel physically normal, just hungrier than they had become used to, and the dedicated page on what happens when you stop tirzepatide covers those biological shifts in plain terms. For a more detailed account of the biological changes, the page on what happens to your body when you stop taking Mounjaro walks through the physiology step by step.
If you stop because of a side effect or because you are unwell, contact your prescriber the same day if you have any concerns. Severe stomach pain, in particular, warrants prompt medical attention regardless of whether you are still taking the medicine.
Yes, tirzepatide can generally be restarted after a break, and the available evidence suggests it remains effective. The medicine acts on receptors that do not become permanently desensitised in the way that, for example, some pain medicines do. People who stop and later restart tend to lose weight again, though clinical data on multiple stop-start cycles is still limited.
Restarting is not simply a case of picking up where you left off at whatever dose you were on. Most prescribers restart from the 2.5mg beginning of the titration schedule, or at least from a reduced dose, to avoid the GI side effects that a full maintenance dose can cause after a period of absence. The prescriber makes that call individually; it is not something to decide alone.
The practical consideration many people overlook is timing. Our prescribers hear this regularly: someone pauses over a busy period or a holiday, intending a short break, and the break extends. Each additional week without treatment makes appetite regulation harder to re-establish and weight creep more difficult to reverse. If you paused recently and are wondering what comes next, the guide on stopping Mounjaro covers the restart question specifically. Thinking about the cost of restarting? The Mounjaro price page sets out what private treatment includes.
Structured lifestyle habits built during treatment are the most robustly evidenced buffer against rapid regain. This is not a vague encouragement to eat less and move more; it means specific, practical habits that are already in place before the last injection, not started after.
Protein intake matters most, practically. Higher protein meals blunt hunger signals more than carbohydrate-equivalent meals do and help preserve lean muscle mass, which is important because weight loss on any medicine includes some muscle as well as fat. Eating enough protein before you stop, not as a crisis measure afterwards, is what the evidence supports.
Resistance training has a meaningful effect on resting metabolic rate and helps counteract the metabolic adaptation that comes with significant weight loss. Even two sessions a week make a difference. Sleep quality is the factor most people underestimate: poor sleep elevates ghrelin, the hunger hormone that tirzepatide has been suppressing, and makes the transition harder.
None of this replaces the medicine. But people who stop Mounjaro in the context of well-established habits typically do better than those who rely on the injection alone. Your prescriber, and where appropriate a dietitian, is the right person to help you build a plan that is specific to your situation. The weight-loss treatment overview explains the options available through nume, including ongoing clinical support, if you are at the point of deciding next steps.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.